Page last updated: 2024-12-07

tris(2-carboxyethyl)phosphine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tris(2-carboxyethyl)phosphine (TCEP) is a widely used reducing agent in biochemistry and molecular biology. It is commonly used to reduce disulfide bonds in proteins, which is important for studying protein structure and function. TCEP is a water-soluble compound that is stable in solution, making it a convenient reagent for reducing disulfide bonds. It is also less toxic than other commonly used reducing agents, such as dithiothreitol (DTT) and β-mercaptoethanol. TCEP is synthesized by reacting phosphine with chloroacetic acid. Its effectiveness as a reducing agent is attributed to its ability to form a stable adduct with disulfide bonds, which facilitates the reduction reaction. The formation of this adduct is reversible, allowing for the regeneration of TCEP and the formation of reduced disulfide bonds. TCEP's ability to reduce disulfide bonds without causing significant oxidation of other molecules makes it an ideal reagent for a wide range of applications, including protein folding, protein purification, and protein crystallization. It is also used in the preparation of antibodies and enzymes. The importance of TCEP lies in its ability to maintain the integrity and activity of proteins by reducing disulfide bonds. The stability and effectiveness of TCEP in biological systems make it an essential reagent in biochemistry and molecular biology research.'

tris(2-carboxyethyl)phosphine: water-soluble reagent which irreversibly reduces disulfides to thiols at room temperature & is active below neutral pH; used for quantitation of iodine and iodate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

TCEP : A tertiary phosphine in which phosphane is substituted with three 2-carboxyethyl groups. It is a commonly used reducing agent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID119411
CHEMBL ID171512
CHEMBL ID2047686
CHEBI ID63213
SCHEMBL ID40381
MeSH IDM0216069

Synonyms (38)

Synonym
tcep
5961-85-3
tris(2-carboxyethyl)phosphine
3,3',3''-phosphanetriyltripropanoic acid
CHEMBL171512
chebi:63213 ,
3-[bis(2-carboxyethyl)phosphanyl]propanoic acid
bdbm50386432
22oac2mo2s ,
unii-22oac2mo2s
3,3',3''-phosphinidynetrispropanoic acid
propanoic acid, 3,3',3''-phosphinidynetris-
AKOS016012327
3,3',3-phosphanetriyltripropanoic acid
CHEMBL2047686 ,
propanoic acid,3,3',3''-phosphinidynetris-
SCHEMBL40381
tcep [mi]
3-[bis-(2-carboxy-ethyl)-phosphanyl]-propionic acid
PZBFGYYEXUXCOF-UHFFFAOYSA-N
3,3',3''-phosphinetriyltripropanoic acid
DTXSID90208290
J-511044
3,3',3''-phosphinetriyltripropanoicacid
Q300902
3,3',3''-phosphanetriyltripropionic acid
tris(2-carboxyethyl) phosphine
(tris(2-carboxyethyl)phosphine)
tcep, hydrochloride salt
A854126
tcep, neutral
CS-0454052
3,3',3''-phosphinylidynetrispropanoic acid
SY275103
mfcd12068446
3,3 inverted exclamation mark ,3 inverted exclamation mark inverted exclamation mark -phosphinetriyltripropanoic acid
BP-27865
115290-70-5

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Therefore, in this study, zebrafish embryos (2-120 h post-fertilization [hpf]) were exposed to TCIPP or TCEP (0, 100, 500 or 2500 μg/L) or a model neurotoxicant, chlorpyrifos (CPF, 100 μg/L) to investigate the adverse effects and possible mechanisms of TCIPP and TCEP on neurodevelopment."( The adverse effect of TCIPP and TCEP on neurodevelopment of zebrafish embryos/larvae.
Feng, C; Li, R; Mi, C; Wang, H; Yang, L; Zhang, L; Zhou, B, 2019
)
0.51
" Our findings provide new insights into the toxic mechanisms of nZVI-TCEP co-exposure to soil organisms, and emphasize the necessity of risk assessment and cautious usage of nanoremediation in newly emerged contaminations."( nZVI-induced iron poisoning aggravated the toxicity of TCEP to earthworm in soil.
He, C; Hou, J; Lin, D; Wu, X; Yang, M; Zhang, J, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Moreover, the expression of main genes related to testosterone (T) synthesis including cytochrome P450 cholesterol side-chain cleavage enzyme (P450scc), cytochrome P450 17α-hydroxysteroid dehydrogenase (P450-17α), 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD) were dramatically reduced by TPP and TCEP treatments, especially with the high dosage for 24h."( TPP and TCEP induce oxidative stress and alter steroidogenesis in TM3 Leydig cells.
Chen, G; Fu, Z; Jin, Y; Liu, L; Qian, H; Wu, Y; Zhang, S, 2015
)
0.42
" Dermal uptake and percutaneous penetration of the OPEs were studied in a Franz diffusion cell system using human skin dosed with a mixture of OPEs in an ethanol:toluene (4:1) solution."( Dermal uptake and percutaneous penetration of organophosphate esters in a human skin ex vivo model.
Clausen, PA; Frederiksen, M; Jensen, NM; Knudsen, LE; Nielsen, F; Nielsen, JB; Stapleton, HM; Sørensen, JA; Sørensen, LS; Vorkamp, K; Webster, TF, 2018
)
0.48
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."(
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
reducing agentThe element or compound in a reduction-oxidation (redox) reaction that donates an electron to another species.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
phosphine derivativeAny phosphorus molecular entity formed by derivatization of a phosphine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID314753Inhibition of carbonic anhydrase 2 assessed as residual activity at 2.5 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251114Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=17.3; PNA:DNA=5b:72005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314749Inhibition of carbonic anhydrase 9 assessed as residual activity at 0.1 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251106Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 2 min; selectivity factor>1; PNA:DNA= 5a:62005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251098Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=57.1; PNA:DNA=5c:82005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251119Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=22.2; PNA:DNA=5c:8b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314755Inhibition of carbonic anhydrase 9 assessed as residual activity at 2.5 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314745Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 0.01 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314744Inhibition of carbonic anhydrase 2 assessed as residual activity at 0.01 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251120Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=25.7; PNA:DNA=5c:8a2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID165312Enzymatic activity of protein tyrosine phosphatase 1B in the presence (10 uM) was measured using para-nitrophenylphosphate (pNPP) as the substrate; active2004Bioorganic & medicinal chemistry letters, Feb-23, Volume: 14, Issue:4
Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B).
AID314748Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 0.1 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314746Inhibition of carbonic anhydrase 9 assessed as residual activity at 0.01 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251117Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=7.4; PNA:DNA=5b:7a2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314751Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 1.0 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314743Inhibition of carbonic anhydrase 9 assessed as residual activity at 0.001 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251097Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=2.9; PNA:DNA=5b:7b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251088Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 2 min; selectivity factor>1; PNA:DNA=5a:62005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251096Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=17.3; PNA:DNA=5b:72005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314758Inhibition of carbonic anhydrase 9 assessed as residual activity at 10 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314750Inhibition of carbonic anhydrase 2 assessed as residual activity at 1.0 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251092Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 2 min; selectivity factor>/=1; PNA:DNA=5a:6b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314747Inhibition of carbonic anhydrase 2 assessed as residual activity at 0.1 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314756Inhibition of carbonic anhydrase 2 assessed as residual activity at 10 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251101Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=22.2; PNA:DNA=5c:8b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314741Inhibition of carbonic anhydrase 2 assessed as residual activity at 0.001 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314752Inhibition of carbonic anhydrase 9 assessed as residual activity at 1.0 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251099Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=7.4; PNA:DNA=5b:7a2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251110Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 2 min; selectivity factor>/=1; PNA:DNA=5a:6b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314757Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 10 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID314742Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 0.001 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
AID251116Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=57.1; PNA:DNA=5c:82005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251102Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 20 min; selectivity factor=25.7; PNA:DNA=5c:8a2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID251115Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 20 min; selectivity factor=2.9; PNA:DNA=5b:7b2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Hybridization dependent cleavage of internally modified disulfide-peptide nucleic acids.
AID314754Inhibition of carbonic anhydrase 9 catalytic domain assessed as residual activity at 2.5 mM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (262)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's28 (10.69)18.2507
2000's78 (29.77)29.6817
2010's113 (43.13)24.3611
2020's43 (16.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.76 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index73.60 (26.88)
Search Engine Supply Index2.24 (0.95)

This Compound (43.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.38%)5.53%
Reviews4 (1.50%)6.00%
Case Studies1 (0.38%)4.05%
Observational1 (0.38%)0.25%
Other259 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]